More than 40 years in x-ray imaging and 18 years exclusively dedicated to the early detection of breast cancer—this is the background of the development of the latest Giotto Digital Mammogrphy System 3D.
Years spent working together with radiologists and radiology technologists with the aim of improving image quality, simplifying the procedures have given them the right tools to successfully achieve their goals. Early detection of breast cancer is now an achieved goal and makes the task more convenient and safer for both the patients and the technologists.
More than 2 million women all over the world have been examined using the Giotto FFDM technology conceived, designed and carried out in IMS R&D laboratories in Italy. Excellent image quality, full dedication to the common task for early detection of breast cancer, designed for patient comfort, with continuous technological advance, along with attention to requirements of radiologists and radiographers are some of the reasons for the success of this amazing mammography unit.
About Fischer Medical Technologies
Fischer’s roots go back to 1910, when H.G. Fischer, the oldest manufacturer of X-ray imaging devices in the United States, began its operation in Chicago, IL. Fischer Medical Technologies LLC is based in Broomfield, Colorado and is the successor company to Fischer Imaging. Fischer Medical was formed in 2006 by the original founders of Fischer Imaging, and acquired the assets of Fischer Imaging, including all patents, trademarks, product designs, and 510(k) filings. Fischer’s focus is on developing differentiated technologies to improve imaging systems’ efficiency and effectiveness though innovative and creative designs. Contact Bob Rusk, Director of the Fischer-Giotto Division at firstname.lastname@example.org.
About IMS Italy
IMS Internazional Medico Scientifica srl was founded in 1965 by Bruno Toniolo, today the IMS president. The company has been active in the world market as a general x-ray manufacturer since 1990 when the GIOTTO mammography unit was launched. Due to the immediate success of this innovative device, today IMS is fully devoted to FFDM, breast biopsy and breast Tomosynthesis. IMS has an extensive R&D department, always working on new projects, including: angiomammography, breast biopsy under Tomo guide, a 3-in-1 system (mammography, prone biopsy and tomosynthesis), and breast density software. For more information, visit www.imsitaly.com